Conversely, EphB3 overexpression suppresses these malignant traits by downregulating this pathway, indicating its tumor-suppressive role and highlighting its potential as a diagnostic and therapeutic target (Xiao et al., 2024). The gene discussed is EPHB3; the disease is neoplasm.